Fig. 2.
Fig. 2. Absolute numbers of (A) CD2, CD16/56, and CD19/20 or (B) CD3, CD3/4, and CD3/8 lymphocytes in peripheral blood during and after treatment with BTI-322.

Absolute numbers of (A) CD2, CD16/56, and CD19/20 or (B) CD3, CD3/4, and CD3/8 lymphocytes in peripheral blood during and after treatment with BTI-322.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal